2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
2X Oncology to Present at Jefferies Global Healthcare Conference
May 31, 2017 13:10 pm UTC| Business
CAMBRIDGE, Mass., May 31, 2017 -- 2X Oncology, Inc. ("2X" or the "Company"), a company focused on developing targeted therapeutics to address significant unmet needs in women’s cancer, today announced that its chief...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave